المؤلفون: Elias, KM, Stone, AB, McGinigle, K, Tankou, JI, Scott, MJ, Fawcett, WJ, Demartines, N, Lobo, DN, Ljungqvist, O, Urman, RD

المصدر: World journal of surgery. 43(1):1-8

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:139986545

المؤلفون: Wijk, L, Udumyan, R, Pache, B, Altman, AD, Williams, LL, Elias, KM, McGee, J, Wells, T, Gramlich, L, Holcomb, K, Achtari, C, Ljungqvist, O, Dowdy, SC, Nelson, G

المصدر: American journal of obstetrics and gynecology. 221(3)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:141815638

المؤلفون: Elias, KM, Emori, MM, Papp, E, Macduffie, E, Konecny, GE, Velculescu, VE, Drapkin, R

المصدر: Gynecologic Oncology. 139(1)

مصطلحات موضوعية: Oncology & Carcinogenesis, Oncology and Carcinogenesis, Paediatrics and Reproductive Medicine

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/7hg2k3cj

المؤلفون: Braga, A, Lima, L, Parente, RCM, Celeste, RK, de Rezende, J, Amim, J, Maesta, I, Sun, SY, Uberti, E, Lin, L, Madi, JM, Viggiano, M, Elias, KM, Horowitz, NS, Berkowitz, RS

المصدر: JOURNAL OF REPRODUCTIVE MEDICINE. 63(5-6):228-239

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:139448779

المؤلفون: Davidowitz, RA, Selfors, LM, Iwanicki, MP, Elias, KM, Karst, A, Piao, H, Ince, TA, Drage, MG, Dering, J, Konecny, GE, Matulonis, U, Mills, GB, Slamon, DJ, Drapkin, R, Brugge, JS

المصدر: The Journal of clinical investigation, vol 124, iss 6
Davidowitz, RA; Selfors, LM; Iwanicki, MP; Elias, KM; Karst, A; Piao, H; et al.(2014). Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. Journal of Clinical Investigation, 124(6), 2611-2625. doi: 10.1172/JCI69815. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4q50b4b6

مصطلحات موضوعية: Epithelial-Mesenchymal Transition, Immunology, Protein Array Analysis, Medical and Health Sciences, Epithelium, Mesoderm, Rare Diseases, Genetics, 2.1 Biological and endogenous factors, Humans, Neoplasm Invasiveness, Aetiology, Peritoneal Neoplasms, Cancer, Ovarian Neoplasms, Homeodomain Proteins, Cultured, Twist-Related Protein 1, Nuclear Proteins, Zinc Finger E-box-Binding Homeobox 1, Ovarian Cancer, Tumor Cells, Gene Knockdown Techniques, Female, Cellular, Snail Family Transcription Factors, Spheroids, Transcriptome, Biotechnology, Transcription Factors

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::77edaf11f963ee4aa2dfaad5e2084ea2
https://escholarship.org/uc/item/4q50b4b6

المؤلفون: Horowitz, NS, Berkowitz, RS, Elias, KM, Horowitz, N S, Berkowitz, R S, Elias, K M

المصدر: BJOG: An International Journal of Obstetrics & Gynaecology; Aug2020, Vol. 127 Issue 9, p1108-1108, 1p

مصطلحات موضوعية: MOLAR pregnancy, CHORIOCARCINOMA, GESTATIONAL trophoblastic disease, TROPHOBLASTIC tumors, ABORTION, MATERNAL age, ENDOWMENT of research, RESEARCH, RESEARCH methodology, EVALUATION research, MEDICAL cooperation, TREATMENT effectiveness, COMPARATIVE studies, RESEARCH funding, DEMOGRAPHY

المؤلفون: Stawiski K; Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland., Fortner RT; Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany., Pestarino L; Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.; Department of Gynecological Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Umu SU; Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway., Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany., Rounge TB; Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.; Centre for Bioinformatics, Department of Pharmacy, University of Oslo, Oslo, Norway., Elias KM; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Fendler W; Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Langseth H; Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

المصدر: Frontiers in oncology [Front Oncol] 2024 Jun 25; Vol. 14, pp. 1389066. Date of Electronic Publication: 2024 Jun 25 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Wollborn L; Brigham and Women's Hospital, Boston, MA, United States., Webber JW; Brigham and Women's Hospital, Boston, United States., Alimena S; Brigham and Women's Hospital, Boston, MA, United States., Mishra S; Brigham and Women's Hospital, Boston, MA, United States., Sussman CB; Harvard Medical School, Boston, United States., Comrie CE; Harvard Medical School, United States., Packard DG; Tufts University, Boston, MA, United States., Williams M; Harvard Medical School, Boston, United States., Russell T; Harvard Medical School, Boston, United States., Fendler W; Medical University of Lodz, Lodz, Poland., Chowdhury D; Dana Farber Cancer Institute, Harvard Medical School, Boston, United States., Elias KM; Brigham and Women's Hospital, Boston, MA, United States.

المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 May 23. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

المؤلفون: Pappas TC; Department of Research & Development, Aspira Women's Health, Austin, TX, United States of America., Roy Choudhury M; Department of Research & Development, Aspira Women's Health, Austin, TX, United States of America., Chacko BK; Aspira Labs, Aspira Women's Health, Austin, TX, United States of America., Twiggs LB; Division of Clinical Operations and Medical Affairs, Aspira Women's Health, Austin, TX, United States of America., Fritsche H; Aspira Labs, Aspira Women's Health, Austin, TX, United States of America., Elias KM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, United States of America; Harvard Medical School, Boston, United States of America., Phan RT; Department of Research & Development, Aspira Women's Health, Austin, TX, United States of America; Aspira Labs, Aspira Women's Health, Austin, TX, United States of America; Division of Clinical Operations and Medical Affairs, Aspira Women's Health, Austin, TX, United States of America. Electronic address: rtphan@caa.columbia.edu.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 May 03; Vol. 187, pp. 21-29. Date of Electronic Publication: 2024 May 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

المؤلفون: Elias KM; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Khan SR; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Stadler E; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Schlub TE; Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Cromer D; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Polizzotto MN; Clinical Hub for Interventional Research and John Curtin School of Medical Research, College of Health and Medicine, The Australian National University, Canberra, ACT, Australia; Canberra Regional Cancer Centre, The Canberra Hospital, Canberra, ACT, Australia., Kent SJ; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia., Turner T; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Davenport MP; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Khoury DS; Kirby Institute, University of New South Wales, Sydney, NSW, Australia. Electronic address: dkhoury@kirby.unsw.edu.au.

المصدر: The Lancet. Microbe [Lancet Microbe] 2024 May; Vol. 5 (5), pp. e459-e467. Date of Electronic Publication: 2024 Apr 04.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/therapy , COVID-19*/immunology , Antiviral Agents*/therapeutic use , Viral Load*/drug effects , SARS-CoV-2*, Humans ; Treatment Outcome ; COVID-19 Drug Treatment ; Outpatients ; Immunization, Passive ; Randomized Controlled Trials as Topic ; COVID-19 Serotherapy ; Disease Progression ; Hospitalization/statistics & numerical data